Claims for Patent: 6,348,216

Summary for Patent: 6,348,216

Title:	Ibuprofen and narcotic analgesic compositions
Abstract:	Provided herein are compositions and methods of making compositions of ibuprofen in combination with a narcotic analgesic. Specifically provided is a pharmaceutical tablet composition comprising ibuprofen; a narcotic analgesic; colloidal silicon dioxide; a filler selected from the group consisting of microcrystalline cellulose and powdered cellulose; a disintegrant selected from the group consisting of croscarmellose sodium, crospovidone, and sodium starch glycolate; a binder consisting of an akylhydroxy methylcellulose; a starch; and a lubricant. Also provided herein is a method of preparing a pharmaceutical tablet composition comprising: (a) Granulating ibuprofen, a narcotic analgesic, a first glidant, a first disintegrant, a binder, and starch to form granules wherein said granulating step comprises a wet granulation process; (b) blending the granules with extra-granular material comprised of a second glidant, a second disintegrant, a filler and starch to form a blend of granules and extra-granular material; and (c) compressing the blend into a tablet.
Inventor(s):	Kushla; Gregory P. (Florham Park, NJ), Lai; Jin-Wang (Edison, NJ), Polli; Gerald P. (Valley Forge, PA)
Assignee:	Knoll Pharmaceutical Company (Mt. Olive, NJ)
Application Number:	08/872,216
Patent Claims:	1. A pharmaceutical tablet comprising a compressed composition substantially free of lactose and polyvinylpyrrolidone, said compressed composition comprising a granule comprised of: a) ibuprofen; b) hydrocodone bitartrate; c) colloidal silicon dioxide; d) a filler selected from the group consisting of microcrystalline cellulose and powdered cellulose; e) a disintegrant; and a f) starch; wherein the granule is formed by a wet granulation process and said granule comprises the ibuprofen and the hydrocodone bitartrate in a single phase; and wherein the composition further comprises an extra granule material comprising a lubricant; and wherein the composition flows well, has good compression performance and can be compressed over a wider range of compression forces with no substantial change in the disintegration time of the tablet; and wherein said ibuprofen, said hydrocodone bitartrate, and said lubricant are present in said tablet in a single phase. 2. A pharmaceutical tablet composition comprising a tablet material comprised of: a) about 25% to about 63%, by total weight of the tablet, of ibuprofen; b) about 0.6% to about 3.8%, by weight, of hydrocodone bitartrate; c) colloidal silicon dioxide wherein the weight of the colloidal silicon dioxide is provided in a range, of the total weight of the tablet, of about 0.5% to about 3%; d) a filler selected from the group consisting of microcrystalline cellulose and powdered cellulose, wherein the weight of the filler is provided in a range, of the total weight of the tablet, of about 10% to about 42%; e) a disintegrant selected from the group consisting of croscarmellose sodium, crospovidone, and sodium starch glycolate wherein the weight of the disintegrant is provided in a range, of the total weight of the tablet, of about 4% to about 10%; f) a binder comprising an alkylhydroxy methylcellulose wherein the weight of the binder is provided in a range, of the total weight of the tablet composition, of about 2% to less than 6%; g) a starch provided in a weight range, of the total weight of the tablet composition, of about 11% to about 20%; and h) a lubricant wherein the lubricant is provided in an amount less than 1% by weight of the total weight of the tablet; and wherein the tablet comprises a compressed blend of a granule and extra granule material and wherein the granule comprises granulate material comprised of: 1) the ibuprofen; 2) the hydrocodone bitartrate; 3) about 0.5% to about 2.0%, of the total weight of the tablet composition, of colloidal silicon dioxide; 4) about 9.5% to about 22%, of the total weight of the tablet composition, of filler; 5) about 4%, of the total weight of the tablet composition, of disintegrant; 6) about 6% to about 12%, of the total weight of the tablet composition of starch; wherein the extra granule material comprises the remaining amount of the tablet material; the composition is substantially free of lactose and polyvinylpyrrolidone and wherein the composition flows well, has good compression performance and can be compressed over a wide range of compression forces with no substantial change in the disintegration time of the tablet. 3. The composition as recited in claim 2 wherein the weight of the filler is provided in range, of the total weight of the tablet composition, of about 15% to about 25%. 4. The composition as recited in claim 2 wherein the weight of the disintegrant is provided in a range of about 6% to about 8%. 5. The composition as recited in claim 3 wherein the weight of the disintegrant is provided in a range of about 6% to about 8%. 6. The composition as recited in claim 2 wherein the weight of the colloidal silicon dioxide is in a range of the total weight of the tablet, of about 1.5% to about 2%. 7. The composition as recited in claim 3 wherein the weight of the colloidal silicon dioxide is in a range, of the total weight of the tablet, of about 1.5% to about 2%. 8. The composition as recited in claim 4 wherein the weight of the colloidal silicon dioxide is in a range, of the total weight of the tablet, of about 1.5% to about 2%. 9. The composition as recited in claim 5 wherein the weight of the colloidal silicon dioxide is in a range, of the total weight of the tablet, of about 1.5% to about 2%. 10. The composition as recited in claim 2 wherein the weight of the binder is in a range, of the total weight of the tablet, of about 3% to about 4%. 11. The composition as recited in claim 3 wherein the weight of the binder is in a range, of the total weight of the tablet, of about 3% to about 4%. 12. The composition as recited in claim 4 wherein the weight of the binder is in a range, of the total weight of the tablet, of about 3% to about 4%. 13. The composition as recited in claim 5 wherein the weight of the binder is in a range, of the total weight of the tablet, of about 3% to about 4%. 14. The composition as recited in claim 6 wherein the weight of the binder is in a range, of the total weight of the tablet, of about 3% to about 4%. 15. The composition as recited in claim 7 wherein the weight of the binder is in a range, of the total weight of the tablet, of about 3% to about 4%. 16. The composition as recited in claim 8 wherein the weight of the binder is in a range, of the total weight of the tablet, of about 3% to about 4%. 17. The composition as recited in claim 9 wherein the weight of the binder is in a range, of the total weight of the tablet, of about 3% to about 4%. 18. The composition as recited in claim 2 wherein the weight of the starch is in a range, of the total weight of the tablet, of about 6% to about 8%. 19. The composition as recited in claim 3 wherein the weight of the starch is in a range, of the total weight of the tablet, of about 6% to about 8%. 20. The composition as recited in claim 4 wherein the weight of the starch is in a range, of the total weight of the tablet, of about 6% to about 8%. 21. The composition as recited in claim 5 wherein the weight of the starch is in a range, of the total weight of the tablet, of about 6% to about 8%. 22. The composition as recited in claim 6 wherein the weight of the starch is in a range, of the total weight of the tablet, of about 6% to about 8%. 23. The composition as recited in claim 7 wherein the weight of the starch is in a range, of the total weight of the tablet, of about 6% to about 8%. 24. The composition as recited in claim 8 wherein the weight of the starch is in a range, of the total weight of the tablet, of about 6% to about 8%. 25. The composition as recited in claim 9 wherein the weight of the starch is in a range, of the total weight of the tablet, of about 6% to about 8%. 26. The composition as recited in claim 10 wherein the weight of the starch is in a range, of the total weight of the tablet, of about 6% to about 8%. 27. The composition as recited in claim 11 wherein the weight of the starch is in a range, of the total weight of the tablet, of about 6% to about 8%. 28. The composition as recited in claim 12 wherein the weight of the starch is in a range, of the total weight of the tablet, of about 6% to about 8%. 29. The composition as recited in claim 13 wherein the weight of the starch is in a range, of the total weight of the tablet, of about 6% to about 8%. 30. The composition as recited in claim 14 wherein the weight of the starch is in a range, of the total weight of the tablet, of about 6% to about 8%. 31. The composition as recited in claim 15 wherein the weight of the starch is in a range, of the total weight of the tablet, of about 6% to about 8%. 32. The composition as recited in claim 16 wherein the weight of the starch is in a range, of the total weight of the tablet, of about 6% to about 8%. 33. The composition as recited in claim 17 wherein the weight of the starch is in a range, of the total weight of the tablet, of about 6% to about 8%. 34. A pharmaceutical composition comprising tablet material comprised of: a) about 50% ibuprofen; b) about 1.88% hydrocodone bitartrate; c) about 1.5% colloidal silicon dioxide; d) about 19.3% microcrystalline cellulose as the filler; e) about 8% sodium croscarmellose as the disintegrant; f) about 3.25% hydroxypropyl methylcellulose as the binder; g) about 15.6% corn starch as the starch; h) about 0.5% magnesium stearate, wherein the total percent of the tablet material is equal to about 100% of the weight of the tablet; wherein the tablet comprises a compressed blend of a granule and extra granulate material wherein the granule comprises as a portion of the tablet material that comprises the total weight of the tablet as follows: a) about 50% ibuprofen; b) about 1.9% hydrocodone bitartrate; c) about 0.75% colloidal silicon dioxide; d) about 9.5% microcrystalline cellulose; e) about 4.0% croscarmellose sodium; f) about 10.6% corn starch; and g) about 3.3% hydroxypropyl methylcellulose; and the extra granule material comprises the remaining amount of tablet material and the composition is substantially free of lactose and polyvinylpyrrolidone.